SELLAS Life Sciences Virtual R&D Day -- October 29, 2025: Advancing Novel Therapies in Acute Myeloid Leukemia (AML): An Overview of the Ongoing Phase 3 REGAL Trial of Galinpepimut-S (GPS) and SLS009 ...
A magistrate judge recommends upholding FinCEN’s anti-money laundering rule for real estate, signaling likely win over FNF.
The most-read coverage of the latest updates in acute myeloid leukemia (AML) for 2025 focused on the evolution of targeted therapies, the promise of off-the-shelf chimeric antigen receptor (CAR) ...
The brokerage industry regulator cited gaps in surveillance, customer due diligence, and red-flag escalation across the ...
Abbvie ($ABBV) announced an update on their ongoing clinical study. AbbVie recently completed a clinical study titled ...
Overview: Smarter AI reduces false alerts, reduces fatigue, and helps teams focus on real financial crime rather than noise. Apparent oversight, expl ...
Panelists discuss how the pathophysiology of acute myeloid leukemia has evolved from a single phenotype understanding to recognizing diverse genetic events that lead to transformation at the ...
What Is Acute Myeloid Leukemia? Acute myeloid leukemia (AML) is a type of blood cancer that starts in your bone marrow, which is the soft inner part of your bones where all your blood cells are made.
The creation of a single supervisor to oversee AML regulation would effectively transfer this responsibility from the ...
The American Society of Hematology/ASH 2025 meeting included AML results from AAML1831, MyeChild01, BIG-1, and PALG-AML1/2016 studies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback